- Biosimilars Series - Forecast Analysis Now Available on ReportsandReports
As the first to introduce guidelines for biosimilar drug approval, Europe has emerged as the testing ground for biosimilar drugs, with biosimilars for three biologics having entered the market to date human growth hormone, epoetin alpha, and filgrastim.
Company: Reportsandreports
(Filed: Fri Feb 05 2010)
- China Healthcare Sector Analysis
“China Healthcare Sector Analysis” report provides extensive information on Chinese pharma market with the detailed description of traditional Chinese medicines and western medicine market.
Company: RNCOS E-Services Pvt. Ltd.
(Filed: Fri Feb 05 2010)
- FACE Foundation Donates 40 Craniofacial Treatments
Milwaukee-based Clinic of Cosmetic Surgery donated 40 craniofacial deformity treatments last year through its foundation to those most in need.
Company: Clinic of Cosmetic Surgery
(Filed: Mon Jan 25 2010)
- Keratoconus in Asians Eyes
People of an Asian heritage are 4.4 to 9.22 times likely to suffer from Keratoconus - the most common degenerative condition of the front window of the eye.
Company: Keratoconus Freedom Group
(Filed: Mon Jan 25 2010)
- Furnasman’s filter guarantees cleaner air
One Hour® Guardian with Pure Sept Hepa stage is engineered to last longer up to five years. Uses technology that get rids of harmful air contents which keeps the air inside your house clean and safe.
Company: Furnasman’s One Hour Heating and Air Conditioning
(Filed: Sun Jan 24 2010)
- Lloydspharmacy unveil new health web tool
Lloydspharmacy has unveiled a new online tool that allows people to work out the state of their work mates' health
Company: Lloydspharmacy
(Filed: Wed Jan 20 2010)
- Corporate giant goes the extra mile to care
Deafness Research UK, the national charity for medical research into hearing impairment, has cited the ConocoPhillips Year of the Ear program as an inspiring example of UK corporate social responsibility. During 2009, ConocoPhillips, the international integrated energy and refining giant, made global efforts to promote awareness of the dangers of noise-induced hearing loss (NIHL) and the ways of maintaining good hearing.
Company: BeyondPR
(Filed: Tue Jan 12 2010)
- New Site Provides Useful Information on Lamictal Anticonvulsant
Lamictal is an anticonvulsant drug which is known to be effective in treating epilepsy and manic depression. It is available as chewable tablets as well, which gives an opportunity for administration even while the patient has a convulsion. While it is proven to be effective, it is not without side effects. The pro and cons of treatment should be well balanced and agreed upon by doctor and patient alike before proceeding to start treatment.
Company: LamictalAnticonvulsant.com
(Filed: Mon Jan 11 2010)
|
